Effect of preoperative oral elatonin on pain intensity

Not Applicable

• Conditions: Cesarean.; Newborn (suspected to be) affected by Cesarean delivery; P03.4

• Registration Number: IRCT20170220032676N3
• Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

Patients who completed the informed consent form
Candidate for non-emergency cesarean section
Lack of sensitivity to Melatonin
Second cesarean section
No history of seizures, diabetes, preeclampsia, eclampsia, hypertension and organ transplantation
who do not use drugs to 24 hours before the intervention
No alcohol or drug abuse
Term pregnancy age

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain intensity. Timepoint: 2, 6, 12 and 24 hours after surgery. Method of measurement: Visual analogue scale (VAS).;The amount of drugs using. Timepoint: 2, 6, 12 and 24 hours after surgery. Method of measurement: Visual analogue scale (VAS).

Secondary Outcome Measures

Name	Time	Method
ausea and vomiting. Timepoint: 2, 6, 12 and 24 hours after surgery. Method of measurement: Visual analogue scale (VAS).;Itching. Timepoint: 2, 6, 12 and 24 hours after surgery. Method of measurement: Visual analogue scale (VAS).;Headache. Timepoint: 2, 6, 12 and 24 hours after surgery. Method of measurement: Visual analogue scale (VAS).